Publications by authors named "Kuntegowdanahalli Chinnagiriyappa Lakshmaiah"
A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India.
Cancer Inform
June 2023
Article Synopsis
- The study aimed to assess the safety, tolerability, immunogenicity, and efficacy of Bevacizumab in patients with solid tumors across various Indian oncology centers.
- It involved 203 patients and reported a total of 338 adverse events, with the most common being gastrointestinal issues and general disorders; 14 serious adverse events were noted but mostly considered unrelated to the treatment.
- At the end of the study, a small percentage of patients developed antibodies to Bevacizumab, but overall safety and efficacy were not affected, with various levels of tumor response observed among participants.
Purpose. Neuroendocrine neoplasms (NENs) of the esophagus are very uncommon with only a few studies published worldwide. Studies on clinical profile, management, and outcomes are very uncommon.
View Article and Find Full Text PDFBackground. The efficacy, safety, and cost benefit of olanzapine (OLN) when compared to aprepitant (APR) in the prevention of chemotherapy induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) were evaluated. Methods.
View Article and Find Full Text PDFThe association of neurofibromatosis type I with invasive male breast cancer is a rare clinical entity with only one case in literature reported in 1953. Women with NF1 are at risk of developing breast cancer and men also may be at risk but there is scarce data on the risk and association of NF1 with male breast cancer due to its rarity. Established clinical trials in male breast cancer patients are lacking and the results are extrapolated from female breast cancer patients.
View Article and Find Full Text PDF